期刊文献+

腹膜后纤维化诊治1例 被引量:1

Diagnosis and treatment of retroperitoneal fibrosis:A case report
下载PDF
导出
摘要 目的提高对腹膜后纤维化罕见疾病的认识水平。方法报告并分析1例腹膜后纤维化IgG4相关硬化性疾病特征及诊治经过。患者左腰部疼痛1年,左下肢麻木3个月来诊。腹部CT考虑左侧腹膜后髂窝处占位性病变,左肾显示不清。行腹膜后肿物切除,受侵乙状结肠切除,降结肠造瘘,受侵左侧输尿管部分切除术。结果患者术后顺利恢复出院,病理为乙状结肠及肿块结肠黏膜慢性炎,结肠浆膜层及壁外见增生之纤维组织玻璃样变伴多量慢性炎细胞浸润结节。结论病因不明的腹膜后广泛进行性纤维组织增生是全身性免疫系统疾病的一种局部表现,手术切除病变解除压迫是治疗的可靠手段,后续治疗可尝试糖皮质激素、免疫抑制剂等。 Objective To improve the understanding of retroperitoneal fibrosis. Methods A patient with retroperitoneal fibrosis, an IgG4-related sclerosing disease was reported. Its clinical characteristics, diagnosis and treatment were analyzed. The patient visited our department due to left lumbar pain for 1 year and left lower extremity numbness for 3 months. Abdominal CT showed an occupying disease in retroperitoneal iliac fossa and unclear left kidney. The retroperitoneal tumor and the involved sigmoid colon were excised. Fistulization was performed for descending colon with the involved left ureter partly removed. Results The patient was recovered and discharged. The patient was diagnosed with chronic inflammation of sigmoid colon tumor and mucositis with fibrous tissue hyaline degeneration in colon serous layer accompanying massive inflammatory cell infiltrative nodules. Conclusion Progressive retroperitoneal fibrous tissue proliferation due to unknown causes is a local manifestation of systemic immune system diseases. Surgical excision is a reliable procedure for the removal of compression caused by the lesion, followed by glucocorticoid hormone and therapy
出处 《解放军医学院学报》 CAS 2013年第6期667-669,共3页 Academic Journal of Chinese PLA Medical School
关键词 腹膜后纤维化 IgG4相关性硬化性疾病 腹部外科 retroperitoneal fibrosis IgG4-related sclerosing disease abdominal surgery
  • 相关文献

参考文献4

二级参考文献42

  • 1[1]Subcommittee for Scleroderma Criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee: Preliminary criteria for the classification of systemic sclerosis[J].Arthritis Rheum,1980,23∶581-586.
  • 2[2]Medsger TA.Systemic sclerosis and localized scleroderma.In: Schumacher HR,eds. Primer on the rheumatic diseases[M].Athlanta: Arthritis Fundation,1988.111-128.
  • 3[3]Chappell LT,Janson M.EDTA chelation therapy in the treatment of vascular disease[J].J Cardiovasc Nurs,1996,10(3)∶78-86.
  • 4[4]Heindorff K,Aurich O,Michaelis A,et al.Genetic toxicology of ethylenediamine tetracetic acid[J].Mutat Res,1983,115(2)∶149-173.
  • 5[3]Moody TE,Vaughan ED Jr.Steroids in the treatment of retroperitoneal fibrosis.J Urol 1979; 121:109-111
  • 6[4]Okazaki K,Chiba T.Autoimmune related pancreatitis.Gut 2002; 51:1-4
  • 7[5]Kamisawa T,Egawa N,Nakajima H,Tsuruta K,Okamoto A,Kamata N.Clinical difficulties in the differentiation of autoimmune pancreatitis and pancreatic carcinoma.Am J Gastroenterol 2003; 98:2694-2699
  • 8[6]Nakazawa T,Ohara H,Sano H,Ando T,Aoki S,Kobayashi S,Okamoto T,Nomura T,Joh T,Itoh M.Clinical differences between primary sclerosing cholangitis and sclerosing cholangitis with autoimmune pancreatitis.Pancreas 2005; 30:20-25
  • 9[7]Dooreck BS,Katz P,Barkin JS.Autoimmune pancreatitis in the spectrum of autoimmune exocrinopathy associated with sialoadenitis and anosmia.Pancreas 2004; 28:105-107
  • 10[8]Kamisawa T,Matsukawa M,Ohkawa M.Autoimmune pancreatitis associated with retroperitoneal fibrosis.JOP 2005;6:260-263

共引文献33

同被引文献3

引证文献1

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部